
Viemed Healthcare VMD
$ 9.06
1.23%
Quarterly report 2025-Q3
added 11-05-2025
Viemed Healthcare Interest Expense 2011-2026 | VMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Viemed Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98 K | 989 K | 1.62 M | 3.95 M | -3 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.95 M | -3 K | 1.33 M |
Quarterly Interest Expense Viemed Healthcare
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44 K | 72 K | 75 K | - | 276 K | -563 K | 26 K | - | 41 K | 2 K | 81 K | - | 57 K | 223 K | 441 K | - | 32 K | 32 K | -55 K | - | 19 K | 3.57 M | - | - | -1 K | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.57 M | -563 K | 230 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 38.78 | -1.25 % | $ 5.78 K | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.15 | 4.22 % | $ 585 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 9.69 | 3.09 % | $ 1.31 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.15 | 4.01 % | $ 155 M | ||
|
Electromed
ELMD
|
78 K | $ 24.26 | 1.17 % | $ 205 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 43.13 | -0.43 % | $ 1.34 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.51 | 0.05 % | $ 121 M | ||
|
AxoGen
AXGN
|
167 K | $ 29.17 | -2.21 % | $ 1.34 B | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.31 | 4.42 % | $ 115 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.53 | 0.68 % | $ 54.5 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 183.14 | 0.27 % | $ 13.7 B | ||
|
Inari Medical
NARI
|
294 K | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.99 | 7.7 % | $ 845 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
548 M | $ 113.59 | 0.01 % | $ 198 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 72.75 | -1.49 % | $ 108 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 105.22 | 0.89 % | $ 1.33 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.31 | 16.67 % | $ 1.4 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 13.05 | 0.23 % | $ 1.96 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 85.73 | 0.55 % | $ 50.1 B |